How Much Does GLP-1 Cost Without Insurance in 2026?

GLP-1 medications can cost over $1,300 a month at the pharmacy, but there are real, legal ways to pay much less. Here's an honest 2026 breakdown.

Majesta Health Medical TeamMedically Reviewed
Reviewed May 1, 20268 min read

Let's just put it on the table: GLP-1 medications can be shockingly expensive if you walk into a pharmacy without insurance. We're going to walk through exactly what they cost in 2026, why they cost that much, and the legitimate ways thousands of Americans are paying a fraction of the sticker price.

This is a friendly, no-spin guide. No upsell. No "miracle cost hack." Just real numbers.

The Sticker Shock

Here's the cash price (in the US, as of 2026) for the most common GLP-1 medications without insurance:

  • Wegovy® (semaglutide for weight loss): ~$1,350/month
  • Ozempic® (semaglutide for type 2 diabetes): ~$970/month
  • Zepbound® (tirzepatide for weight loss): ~$1,060/month
  • Mounjaro® (tirzepatide for type 2 diabetes): ~$1,080/month
  • Saxenda® (liraglutide, daily): ~$1,300/month
  • That's roughly $12,000–$16,000 per year at full retail. For most American families, that's not realistic.

    So why are these so expensive? A few reasons:

    1. They're under patent. Pharma companies invested billions developing them and have exclusivity until the patents expire (mostly in 2031–2033 for semaglutide, later for tirzepatide). 2. Massive demand. The companies have no incentive to lower prices when supply is constrained. 3. The US drug pricing system. In other countries, the same medications cost a fraction of what they do here. (In Germany, Wegovy retails for about $300/month. Same drug.)

    Knowing why doesn't make it more affordable, but it does explain why so many patients are looking for alternatives.

    Insurance Coverage in 2026

    Insurance coverage for GLP-1 weight loss medications is improving but still inconsistent. Here's the lay of the land:

  • Medicare: Still does not cover GLP-1s for obesity alone. It does cover them for diabetes and (as of late 2024) for cardiovascular risk reduction in eligible patients with overweight/obesity and known heart disease.
  • Medicaid: Coverage varies wildly by state. About half of state Medicaid programs cover GLP-1s for obesity.
  • Commercial insurance: Roughly half of US employer plans cover GLP-1 weight loss medications. Even when covered, copays can range from $25 to $250+ per month, and prior authorization is almost always required.
  • VA / TRICARE: Coverage exists but with strict criteria.
  • The hard truth: even with insurance, many patients still pay several hundred dollars out of pocket per month, or get denied entirely.

    Manufacturer Discounts and Coupons

    Both major GLP-1 manufacturers offer programs that can lower costs:

  • Wegovy® savings card: Eligible commercially insured patients may pay as little as $0 per month for a limited time. Cash-pay patients can sometimes access a self-pay option around $499/month for a 28-day supply (eligibility and pricing change frequently).
  • Zepbound® savings card: Eligible commercially insured patients can sometimes pay as little as $25/month. A self-pay vial program offers single-dose vials at lower prices than the auto-injector pens.
  • These programs come with eligibility rules, usually you can't have government insurance to qualify for the commercial discount, and the self-pay programs often require valid prescriptions and direct-from-manufacturer delivery.

    Always check the manufacturer's official website for current pricing and rules.

    Compounded Semaglutide and Tirzepatide

    For many cash-pay patients, compounded GLP-1 medications have become the most accessible option.

    A compounded medication is one prepared by a licensed compounding pharmacy using FDA-approved active pharmaceutical ingredients. Because compounded versions don't carry the same brand markup, prices are dramatically lower:

  • Compounded semaglutide: typically $179–$399/month (depending on dose and provider)
  • Compounded tirzepatide: typically $349–$599/month
  • A few important things to know:

  • The active ingredient is the same molecule that's in the brand-name drug.
  • Quality matters. A reputable provider only works with 503A or 503B compounding pharmacies that are registered with the FDA, follow USP standards, and use certified active ingredients.
  • The FDA has flagged compounded GLP-1s as a category, meaning during shortages, compounding was permitted; outside shortages, only patient-specific compounding (e.g., needed for an allergy or different dose) is generally allowed.
  • If you're considering compounded medication, work only with telehealth providers who can clearly explain their pharmacy partners, ingredient sourcing, and clinician oversight. (At Majesta Health, this is non-negotiable.)

    Real-World Monthly Cost Examples in 2026

    Here's what real patients are actually paying:

    *Scenario 1: Insured with covered Wegovy*

  • $50–$150 copay/month after meeting deductible
  • Annual: $600–$1,800
  • *Scenario 2: Insured but Wegovy not covered, using manufacturer cash program*

  • $499/month
  • Annual: ~$6,000
  • *Scenario 3: Cash-pay through telehealth with compounded semaglutide*

  • $179–$299/month including consults
  • Annual: $2,148–$3,588
  • *Scenario 4: Cash-pay through telehealth with compounded tirzepatide*

  • $349–$499/month including consults
  • Annual: $4,188–$5,988
  • For most uninsured or under-insured patients, telehealth compounded programs offer the best balance of affordability and access, *when* the provider is reputable.

    Hidden Costs to Watch For

    When comparing programs, look beyond the headline price:

  • Consult fees (sometimes billed separately)
  • Lab work (some providers require baseline labs you'll pay for)
  • Shipping
  • Pen/syringe supplies
  • Cancellation fees
  • Auto-renewal traps, read the fine print
  • A trustworthy program will be transparent about every line item.

    Is the Cost Worth It?

    This is a personal decision, but it's worth thinking about in context.

    Obesity-related healthcare costs in the US average $1,861 more per year for adults with obesity than those without (CDC data). Add the cost of weight-related comorbidities, type 2 diabetes, heart disease, joint problems, sleep apnea, and the long-term financial picture changes dramatically.

    The STEP and SURMOUNT trials showed that effective GLP-1 treatment can reduce or even reverse many of these conditions. *Results may vary, and lifestyle still plays a major role.*

    That doesn't mean a GLP-1 is the right financial choice for everyone. But it means the math is more nuanced than "monthly subscription cost."

    How Majesta Health Approaches Cost

    We built Majesta Health specifically because we saw thousands of people priced out of safe, effective weight loss care.

    Our approach:

  • Transparent flat monthly pricing, no surprise fees
  • Compounded semaglutide and tirzepatide sourced through licensed US compounding pharmacies
  • Licensed clinician oversight included in your membership
  • Free shipping, easy refills, and real human support
  • No long-term contracts
  • If you've been priced out of GLP-1 treatment and want to see what's actually possible, we'd love to help you find out.

    Take our free 2-minute assessment to see what your monthly cost could look like and whether you're a clinical fit.

    Take the free 2-minute assessment →


    This article is for informational purposes only and does not constitute medical advice. Pricing reflects 2026 estimates and may change. Results may vary.

    Ready to Reserve Your Spot?

    Join the founding-member waitlist for priority access and locked-in pricing.

    Join the Waitlist